市場調査レポート概要
目次
Description
Table of Contents
Figures
List of Tables Table 1. Global Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Varicella Vaccine Table 3. Key Players of Influenza Vaccine Table 4. Key Players of Polio Vaccine Table 5. Key Players of Hepatitis A Vaccine Table 6. Key Players of Rabies Vaccine Table 7. Key Players of BCG Vaccine Table 8. Key Players of Hepatitis B Table 9. Key Players of Pertussis, Diphtheria, Tetanus Table 10. Key Players of Pneumococcal Table 11. Key Players of Others Table 12. Global Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 13. Global Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 14. Global Vaccine Market Size by Region (2019-2024) & (US$ Million) Table 15. Global Vaccine Market Share by Region (2019-2024) Table 16. Global Vaccine Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 17. Global Vaccine Market Share by Region (2025-2030) Table 18. Vaccine Market Trends Table 19. Vaccine Market Drivers Table 20. Vaccine Market Challenges Table 21. Vaccine Market Restraints Table 22. Global Vaccine Revenue by Players (2019-2024) & (US$ Million) Table 23. Global Vaccine Revenue Share by Players (2019-2024) Table 24. Global Top Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine as of 2023) Table 25. Global Vaccine Industry Ranking 2022 VS 2023 VS 2024 Table 26. Global 5 Largest Players Market Share by Vaccine Revenue (CR5 and HHI) & (2019-2024) Table 27. Global Key Players of Vaccine, Headquarters and Area Served Table 28. Global Key Players of Vaccine, Product and Application Table 29. Global Key Players of Vaccine, Product and Application Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Vaccine Market Size by Type (2019-2024) & (US$ Million) Table 32. Global Vaccine Revenue Market Share by Type (2019-2024) Table 33. Global Vaccine Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 34. Global Vaccine Revenue Market Share by Type (2025-2030) Table 35. Global Vaccine Market Size by Application (2019-2024) & (US$ Million) Table 36. Global Vaccine Revenue Share by Application (2019-2024) Table 37. Global Vaccine Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 38. Global Vaccine Revenue Share by Application (2025-2030) Table 39. North America Vaccine Market Size by Type (2019-2024) & (US$ Million) Table 40. North America Vaccine Market Size by Type (2025-2030) & (US$ Million) Table 41. North America Vaccine Market Size by Application (2019-2024) & (US$ Million) Table 42. North America Vaccine Market Size by Application (2025-2030) & (US$ Million) Table 43. North America Vaccine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 44. North America Vaccine Market Size by Country (2019-2024) & (US$ Million) Table 45. North America Vaccine Market Size by Country (2025-2030) & (US$ Million) Table 46. Europe Vaccine Market Size by Type (2019-2024) & (US$ Million) Table 47. Europe Vaccine Market Size by Type (2025-2030) & (US$ Million) Table 48. Europe Vaccine Market Size by Application (2019-2024) & (US$ Million) Table 49. Europe Vaccine Market Size by Application (2025-2030) & (US$ Million) Table 50. Europe Vaccine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 51. Europe Vaccine Market Size by Country (2019-2024) & (US$ Million) Table 52. Europe Vaccine Market Size by Country (2025-2030) & (US$ Million) Table 53. China Vaccine Market Size by Type (2019-2024) & (US$ Million) Table 54. China Vaccine Market Size by Type (2025-2030) & (US$ Million) Table 55. China Vaccine Market Size by Application (2019-2024) & (US$ Million) Table 56. China Vaccine Market Size by Application (2025-2030) & (US$ Million) Table 57. Asia Vaccine Market Size by Type (2019-2024) & (US$ Million) Table 58. Asia Vaccine Market Size by Type (2025-2030) & (US$ Million) Table 59. Asia Vaccine Market Size by Application (2019-2024) & (US$ Million) Table 60. Asia Vaccine Market Size by Application (2025-2030) & (US$ Million) Table 61. Asia Vaccine Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 62. Asia Vaccine Market Size by Region (2019-2024) & (US$ Million) Table 63. Asia Vaccine Market Size by Region (2025-2030) & (US$ Million) Table 64. Middle East, Africa, and Latin America Vaccine Market Size by Type (2019-2024) & (US$ Million) Table 65. Middle East, Africa, and Latin America Vaccine Market Size by Type (2025-2030) & (US$ Million) Table 66. Middle East, Africa, and Latin America Vaccine Market Size by Application (2019-2024) & (US$ Million) Table 67. Middle East, Africa, and Latin America Vaccine Market Size by Application (2025-2030) & (US$ Million) Table 68. Middle East, Africa, and Latin America Vaccine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 69. Middle East, Africa, and Latin America Vaccine Market Size by Country (2019-2024) & (US$ Million) Table 70. Middle East, Africa, and Latin America Vaccine Market Size by Country (2025-2030) & (US$ Million) Table 71. AstraZeneca Company Details Table 72. AstraZeneca Business Overview Table 73. AstraZeneca Vaccine Product Table 74. AstraZeneca Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 75. AstraZeneca Recent Developments Table 76. BioNTech Company Details Table 77. BioNTech Business Overview Table 78. BioNTech Vaccine Product Table 79. BioNTech Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 80. BioNTech Recent Developments Table 81. Boehringer-Ingelheim Company Details Table 82. Boehringer-Ingelheim Business Overview Table 83. Boehringer-Ingelheim Vaccine Product Table 84. Boehringer-Ingelheim Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 85. Boehringer-Ingelheim Recent Developments Table 86. CCBIO Company Details Table 87. CCBIO Business Overview Table 88. CCBIO Vaccine Product Table 89. CCBIO Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 90. CCBIO Recent Developments Table 91. CSL Company Details Table 92. CSL Business Overview Table 93. CSL Vaccine Product Table 94. CSL Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 95. CSL Recent Developments Table 96. CureVac Company Details Table 97. CureVac Business Overview Table 98. CureVac Vaccine Product Table 99. CureVac Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 100. CureVac Recent Developments Table 101. Elanco Company Details Table 102. Elanco Business Overview Table 103. Elanco Vaccine Product Table 104. Elanco Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 105. Elanco Recent Developments Table 106. GSK Company Details Table 107. GSK Business Overview Table 108. GSK Vaccine Product Table 109. GSK Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 110. GSK Recent Developments Table 111. Hulan Bio Company Details Table 112. Hulan Bio Business Overview Table 113. Hulan Bio Vaccine Product Table 114. Hulan Bio Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 115. Hulan Bio Recent Developments Table 116. Indian Immunologicals Company Details Table 117. Indian Immunologicals Business Overview Table 118. Indian Immunologicals Vaccine Product Table 119. Indian Immunologicals Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 120. Indian Immunologicals Recent Developments Table 121. Merck Company Details Table 122. Merck Business Overview Table 123. Merck Vaccine Product Table 124. Merck Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 125. Merck Recent Developments Table 126. Minhai Biotechnology Company Details Table 127. Minhai Biotechnology Business Overview Table 128. Minhai Biotechnology Vaccine Product Table 129. Minhai Biotechnology Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 130. Minhai Biotechnology Recent Developments Table 131. Mitsubishi Tanabe Pharma Company Details Table 132. Mitsubishi Tanabe Pharma Business Overview Table 133. Mitsubishi Tanabe Pharma Vaccine Product Table 134. Mitsubishi Tanabe Pharma Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 135. Mitsubishi Tanabe Pharma Recent Developments Table 136. Moderna Therapeutics Company Details Table 137. Moderna Therapeutics Business Overview Table 138. Moderna Therapeutics Vaccine Product Table 139. Moderna Therapeutics Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 140. Moderna Therapeutics Recent Developments Table 141. Mylan Company Details Table 142. Mylan Business Overview Table 143. Mylan Vaccine Product Table 144. Mylan Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 145. Mylan Recent Developments Table 146. Plumbline Life Sciences Company Details Table 147. Plumbline Life Sciences Business Overview Table 148. Plumbline Life Sciences Vaccine Product Table 149. Plumbline Life Sciences Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 150. Plumbline Life Sciences Recent Developments Table 151. Sanofi Company Details Table 152. Sanofi Business Overview Table 153. Sanofi Vaccine Product Table 154. Sanofi Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 155. Sanofi Recent Developments Table 156. Translate Bio Company Details Table 157. Translate Bio Business Overview Table 158. Translate Bio Vaccine Product Table 159. Translate Bio Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 160. Translate Bio Recent Developments Table 161. Walvax Biotechnology Company Details Table 162. Walvax Biotechnology Business Overview Table 163. Walvax Biotechnology Vaccine Product Table 164. Walvax Biotechnology Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 165. Walvax Biotechnology Recent Developments Table 166. Wuhan Institute of Biological Products Company Details Table 167. Wuhan Institute of Biological Products Business Overview Table 168. Wuhan Institute of Biological Products Vaccine Product Table 169. Wuhan Institute of Biological Products Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 170. Wuhan Institute of Biological Products Recent Developments Table 171. Zoties Company Details Table 172. Zoties Business Overview Table 173. Zoties Vaccine Product Table 174. Zoties Revenue in Vaccine Business (2019-2024) & (US$ Million) Table 175. Zoties Recent Developments Table 176. Research Programs/Design for This Report Table 177. Key Data Information from Secondary Sources Table 178. Key Data Information from Primary Sources List of Figures Figure 1. Global Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Vaccine Market Share by Type: 2023 VS 2030 Figure 3. Varicella Vaccine Features Figure 4. Influenza Vaccine Features Figure 5. Polio Vaccine Features Figure 6. Hepatitis A Vaccine Features Figure 7. Rabies Vaccine Features Figure 8. BCG Vaccine Features Figure 9. Hepatitis B Features Figure 10. Pertussis, Diphtheria, Tetanus Features Figure 11. Pneumococcal Features Figure 12. Others Features Figure 13. Global Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 14. Global Vaccine Market Share by Application: 2023 VS 2030 Figure 15. For Adult Case Studies Figure 16. For Child Case Studies Figure 17. Vaccine Report Years Considered Figure 18. Global Vaccine Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 19. Global Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 20. Global Vaccine Market Share by Region: 2023 VS 2030 Figure 21. Global Vaccine Market Share by Players in 2023 Figure 22. Global Top Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine as of 2023) Figure 23. The Top 10 and 5 Players Market Share by Vaccine Revenue in 2023 Figure 24. North America Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 25. North America Vaccine Market Share by Type (2019-2030) Figure 26. North America Vaccine Market Share by Application (2019-2030) Figure 27. North America Vaccine Market Share by Country (2019-2030) Figure 28. United States Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 29. Canada Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. Europe Vaccine Market Size YoY (2019-2030) & (US$ Million) Figure 31. Europe Vaccine Market Share by Type (2019-2030) Figure 32. Europe Vaccine Market Share by Application (2019-2030) Figure 33. Europe Vaccine Market Share by Country (2019-2030) Figure 34. Germany Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 35. France Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 36. U.K. Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 37. Italy Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 38. Russia Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 39. Nordic Countries Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 40. China Vaccine Market Size YoY (2019-2030) & (US$ Million) Figure 41. China Vaccine Market Share by Type (2019-2030) Figure 42. China Vaccine Market Share by Application (2019-2030) Figure 43. Asia Vaccine Market Size YoY (2019-2030) & (US$ Million) Figure 44. Asia Vaccine Market Share by Type (2019-2030) Figure 45. Asia Vaccine Market Share by Application (2019-2030) Figure 46. Asia Vaccine Market Share by Region (2019-2030) Figure 47. Japan Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 48. South Korea Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 49. China Taiwan Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 50. Southeast Asia Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 51. India Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 52. Australia Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 53. Middle East, Africa, and Latin America Vaccine Market Size YoY (2019-2030) & (US$ Million) Figure 54. Middle East, Africa, and Latin America Vaccine Market Share by Type (2019-2030) Figure 55. Middle East, Africa, and Latin America Vaccine Market Share by Application (2019-2030) Figure 56. Middle East, Africa, and Latin America Vaccine Market Share by Country (2019-2030) Figure 57. Brazil Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 58. Mexico Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 59. Turkey Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 60. Saudi Arabia Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 61. Israel Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 62. GCC Countries Vaccine Market Size YoY Growth (2019-2030) & (US$ Million) Figure 63. AstraZeneca Revenue Growth Rate in Vaccine Business (2019-2024) Figure 64. BioNTech Revenue Growth Rate in Vaccine Business (2019-2024) Figure 65. Boehringer-Ingelheim Revenue Growth Rate in Vaccine Business (2019-2024) Figure 66. CCBIO Revenue Growth Rate in Vaccine Business (2019-2024) Figure 67. CSL Revenue Growth Rate in Vaccine Business (2019-2024) Figure 68. CureVac Revenue Growth Rate in Vaccine Business (2019-2024) Figure 69. Elanco Revenue Growth Rate in Vaccine Business (2019-2024) Figure 70. GSK Revenue Growth Rate in Vaccine Business (2019-2024) Figure 71. Hulan Bio Revenue Growth Rate in Vaccine Business (2019-2024) Figure 72. Indian Immunologicals Revenue Growth Rate in Vaccine Business (2019-2024) Figure 73. Merck Revenue Growth Rate in Vaccine Business (2019-2024) Figure 74. Minhai Biotechnology Revenue Growth Rate in Vaccine Business (2019-2024) Figure 75. Mitsubishi Tanabe Pharma Revenue Growth Rate in Vaccine Business (2019-2024) Figure 76. Moderna Therapeutics Revenue Growth Rate in Vaccine Business (2019-2024) Figure 77. Mylan Revenue Growth Rate in Vaccine Business (2019-2024) Figure 78. Plumbline Life Sciences Revenue Growth Rate in Vaccine Business (2019-2024) Figure 79. Sanofi Revenue Growth Rate in Vaccine Business (2019-2024) Figure 80. Translate Bio Revenue Growth Rate in Vaccine Business (2019-2024) Figure 81. Walvax Biotechnology Revenue Growth Rate in Vaccine Business (2019-2024) Figure 82. Wuhan Institute of Biological Products Revenue Growth Rate in Vaccine Business (2019-2024) Figure 83. Zoties Revenue Growth Rate in Vaccine Business (2019-2024) Figure 84. Bottom-up and Top-down Approaches for This Report Figure 85. Data Triangulation Figure 86. Key Executives Interviewed
